pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Pulmonology · news · pharmadog
← back to Pulmonology
News · Pulmonology
512
stories
26d
Amgen’s T cell engager notches new major lung cancer victory
endpoints
26d
STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals
stat
26d
Sanofi spells out asthma data, AstraZeneca details COPD win at #ERS26
endpoints
26d
Inhibrx’s OX40 agonist add-on beats Keytruda alone in head and neck cancer
biospace
26d
Novo shutters 2 more heart disease studies, indicating IL-6 is ‘invalid target’
biospace
26d
Roivant's pulmonary hypertension drug shines with ‘blowout’ Phase 2 data
biospace
26d
STAT+: Oura files to goes public, reported $1.2B in earnings
stat
26d
STAT+: FDA approves AstraZeneca breast cancer drug
stat
26d
STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more
stat
26d
STAT+: AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies
stat
26d
STAT+: Inhibrx claims first win for long-sought immunotherapy target
stat
26d
AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD
fiercebiotech
26d
STAT+: Roivant lung disease drug hits mid-stage study goals
stat
26d
#ERS26: Roivant reports Phase 2 win for lung disease drug that it got from Bayer
endpoints
26d
#ERS26: Beam says AATD base editing data hold up after one year
endpoints
27d
BMC Medical Co., Ltd. Recalls Luna G3 APAP (Model LG3600) Devices with Firmware G3-2.00.76 Configured with G3 A20-31.cfg
fda medwatch
27d
BMC Medical Co., Ltd. Recalls Luna G3 APAP (Model LG3600) with Firmware G3-2.00.76 Due to Firmware Defect
fda medwatch
27d
Inhibrx CEO says progression-free survival data leave ‘no question’ about OX40 agonist’s durability
fiercebiotech
29d
Roivant’s $14M bet on Bayer’s inhaled hypertension med pays off with phase 2 win
fiercebiotech
Sep 4, 26
Novartis Lp(a) drug fails to lower cardiovascular risk in closely watched ph. 3 trial
fiercebiotech
Sep 4, 26
STAT+: We’re reading about a Bristol CAR-T trial pause, Pfizer offloading a shelved candidate, and more
stat
Sep 4, 26
Ionis’ rare neurology drug approved; Pfizer inks an ADC deal
biopharma dive
Sep 4, 26
Pfizer punts Seagen ADC, further muddying value of the $43B buyout
biospace
Sep 4, 26
Opinion: Make infectious disease data boring again
stat
Sep 3, 26
American Regent, Inc. Issues Voluntary Nationwide Recall of Three Lots of Epinephrine Injection, USP 30 mg/ 30 mL (1 mg/mL) Due to the Presence of Particulate Matter and Lack of Assurance of Sterility
fda recalls
Sep 3, 26
‘Tactical athletes’ get new guidance for cardiovascular fitness
stat
Sep 3, 26
GSK wagers up to $1.3B on a different kind of cancer drug
biopharma dive
Sep 3, 26
Pfizer shares ADC rights with Medicus; RevMed updates lung cancer data
endpoints
Sep 3, 26
RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer
biospace
Sep 3, 26
Summit, Akeso’s ivonescimab bests Merck’s Keytruda in China trial—again
biospace
← prev
page 5 of 18
next →
